abstract |
The present invention provides azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as well as its compositions and methods of use that modulate the activity of Janus kinase (JAK) and which are useful in the treatment of diseases related to JAK activity which includes , for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases. |